PITTSBURG – Cancer patients receiving chemotherapy treatment were able to use a smartphone and wearable device to monitor their symptoms from treatment in a study published recently in JMIR. The goal of the study was to prevent unnecessary doctor or hospital visits and improve quality of life, the researchers wrote in the journal article. Researchers from the University of Pittsburg monitored 14 patients who carried a smartphone and Fitbit device, which provided data to physicians on mobility, sleep, activity and communication. A smartphone app developed by researchers passively collected data on patient behavior patterns, which was then used to develop an algorithm that could identify and correlate the patient’s high-symptom, average-symptom and low-symptom days with 88% accuracy. “These findings highlight opportunities for long-term monitoring of cancer patients during chemotherapy with minimal patient burden, as well as real-time adaptive interventions aimed at early management of worsening or severe symptoms,” the researchers wrote.
You are here: / / Smartphone, Fitbit can help monitor chemotherapy patients